LOGIN

REGISTER
Seeker

Test Start of treatment: time of action, adherence, and clinical response

QUESTION 1: WHAT IS THE PHASE OF DEPRESSION TREATMENT IN WHICH INITIAL SYMPTOMS ARE RELIEVED?

SECOND QUESTION: HOW LONG DOES IT TAKE FOR THE EFFECTS OF ANTIDEPRESSANTS, ESPECIALLY SSRIs, TO BECOME NOTICEABLE?

QUESTION 3: WHAT IS MEANT BY “RELAPSE” IN THE TREATMENT OF DEPRESSION?

QUESTION 4: WHICH OF THE FOLLOWING IS A STRATEGY USED IN RESISTANT DEPRESSION TO IMPROVE RESPONSE TO TREATMENT?

QUESTION 5: WHICH NEUROMODULATION THERAPY IS THE LEAST INVASIVE AND IS USED IN CASES OF RESISTANT DEPRESSION?

QUESTION 6: WHAT PERCENTAGE OF PATIENTS WITH DEPRESSION DO NOT ACHIEVE COMPLETE REMISSION AFTER TWO APPROPRIATE TREATMENTS?

QUESTION 7: WHAT IS ONE COMMON REASON FOR PATIENTS TO DISCONTINUE ANTIDEPRESSANT TREATMENT EARLY?

QUESTION 8: IN SEVERE CASES OF DEPRESSION, WHAT TYPE OF ADDITIONAL TREATMENT MAY BE CONSIDERED IF OTHER TREATMENTS HAVE NOT BEEN SUCCESSFUL?

This test is only available to students who have purchased the course
INCORRECT QUESTIONS

Are there any errors or improvements?

Where is the error?

What is the error?